Literature DB >> 15568769

Cucurbitane triterpenoids from Leucopaxillus gentianeus.

Marco Clericuzio1, Mariella Mella, Paola Vita-Finzi, Michele Zema, Giovanni Vidari.   

Abstract

In addition to the known bioactive triterpene cucurbitacin B (1), two new cucurbitane triterpenoids, namely, leucopaxillones A (3) and B (4), exhibiting a new oxygenation pattern among cucurbitacins, have been isolated from the mushroom Leucopaxillus gentianeus (syn. L. amarus). Cucurbitacin B (1) imparts a bitter taste to the flesh of the fungus; however, it occurs in the fruiting bodies mainly esterified as tasteless fatty acid esters 2a-c. In vitro growth inhibitory effects of compounds 1-4 on proliferation of four different human tumor cell lines (A549, CAKI-1, HepG2, MCF-7) were evaluated by using a 1-day MTT assay. Only cucurbitacin B was highly active on all lines. Free cucurbitacin B is presumed to be formed in vivo by an enzyme-mediated scission of esters 2a-c, thus constituting a chemical weapon that protects the mushrooms against parasites and predators. Compounds 1-4 are structurally different from the other few cucurbitacins isolated from Basidiomycetes, being, instead, more similar to those occurring in plants. In particular, cucurbitacin B (1) seems to represent an interesting example of secondary metabolite convergence between distant taxa such as fungi and vascular plants, where they likely exert a similar role of protection. The structures of the compounds were established by means of spectroscopic methods and X-ray diffraction on a single crystal. The absolute configuration of leucopaxillone A has been assigned on the basis of CD chirality rules.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15568769     DOI: 10.1021/np049883o

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  6 in total

Review 1.  Use of cucurbitacins for lung cancer research and therapy.

Authors:  Min Liu; Qijia Yan; Bi Peng; Yuan Cai; Shuangshuang Zeng; Zhijie Xu; Yuanliang Yan; Zhicheng Gong
Journal:  Cancer Chemother Pharmacol       Date:  2021-04-06       Impact factor: 3.333

2.  Novel Triterpenoid Alkaloids With Their Potential Cytotoxic Activity From the Roots of Siraitia grosvenorii.

Authors:  Huijuan Wang; Guoxu Ma; Huaxiang Wang; Lingyu Li; Aijun Dong; Huiping Liu; Xiaoshuang Huo; Jianyong Si; Junchi Wang
Journal:  Front Chem       Date:  2022-04-29       Impact factor: 5.545

3.  Cucurbitacins - a promising target for cancer therapy.

Authors:  Abdullah A Alghasham
Journal:  Int J Health Sci (Qassim)       Date:  2013-01

4.  Inhibitory effects of cucurbitacin B on laryngeal squamous cell carcinoma.

Authors:  Tingyan Liu; Meixia Zhang; Hongliang Zhang; Chunyan Sun; Yihui Deng
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-02-29       Impact factor: 2.503

5.  Anti-Stress and Glial Differentiation Effects of a Novel Combination of Cucurbitacin B and Withanone (CucWi-N): Experimental Evidence.

Authors:  Sukant Garg; Sunil C Kaul; Renu Wadhwa
Journal:  Ann Neurosci       Date:  2018-07-05

6.  Antibacterial and antioxidant activities of extracts and isolated compounds from the roots extract of Cucumis prophetarum and in silico study on DNA gyrase and human peroxiredoxin 5.

Authors:  Wario Galma; Milkyas Endale; Emebet Getaneh; Rajalakshmanan Eswaramoorthy; Temesgen Assefa; Yadessa Melaku
Journal:  BMC Chem       Date:  2021-05-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.